Alert Center: Two Pfizer doses protect 70% against hospitalization from omicron
A new study has found that two doses of the Pfizer COVID-19 vaccine are 70% effective against the omicron variant.
•
Dec 14, 2021, 11:25 AM
•
Updated 955 days ago
Share:
More Stories
Hometown Heroes in the Hudson Valley
2ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
147ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
168ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
295ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
295ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds agoHometown Heroes in the Hudson Valley
2ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
147ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
168ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
295ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
295ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds agoA new study has found that two
doses of the Pfizer COVID-19 vaccine are 70% effective against the omicron
variant.
The study out of South Africa says the
two Pfizer doses are 70% effective at preventing hospitalization and
33% effective at preventing infections.
The study was performed by South
Africa Insurance Company Discovery Limited and examined about 78,000 omicron
cases from Nov. 15 to Dec. 7.
They say the protection is the same
across age groups and illness.
